Loading...
3S Corporation — Tofacitinib Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #13 for Tofacitinib · $16.1K export value · DGFT Verified
3S Corporation is the #13 Indian exporter of Tofacitinib with $16.1K in export value and 51 verified shipments. 3S Corporation holds a 0.4% market share in Tofacitinib exports across 1 countries. The company exports 13 pharmaceutical products worth $505.4K across 4 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $450.0K | 9 | 26.4% |
| UNITED STATES | $400.0K | 8 | 23.5% |
| IRAQ | $203.4K | 87 | 11.9% |
| GUATEMALA | $188.1K | 9 | 11.0% |
| MALAYSIA | $163.4K | 14 | 9.6% |
| CHILE | $39.9K | 100 | 2.3% |
| TANZANIA | $37.5K | 10 | 2.2% |
| KENYA | $35.2K | 41 | 2.1% |
| UGANDA | $34.9K | 13 | 2.1% |
| UNITED ARAB EMIRATES | $33.3K | 54 | 2.0% |
India exports Tofacitinib to 67 countries. The top destination is CANADA (26.4%), followed by UNITED STATES and IRAQ.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TARO PHARMACEUTICALS INC., | CANADA | $200.0K | 4 |
| NILA JAMAL ENTERPRISE | MALAYSIA | $163.4K | 14 |
| TARO PHARMACEUTICALS INC. | CANADA | $150.0K | 3 |
| VMG HEALTHCARE PRODUCTS GUATEMALA S | GUATEMALA | $150.0K | 3 |
| TARO PHARMACEUTICALS INC | CANADA | $100.0K | 2 |
| ATLAS TRADING COMPANY |
India exported $1.2M worth of Tofacitinib through 814 shipments from 119 suppliers to 67 countries, serving 213 buyers globally. 3S Corporation contributes $16.1K to this total, accounting for 0.4% of India's Tofacitinib exports.
3S Corporation's average Tofacitinib shipment value is $316 per consignment, based on 51 shipments totaling $16.1K.
3S Corporation ranks #13 among 119 Indian Tofacitinib exporters with a 0.4% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($450.0K), AJANTA PHARMA LIMITED ($172.4K), BABA AGENCIES ($163.4K). 3S Corporation processed 51 shipments to 1 destination countries.
What 3S Corporation must comply with to export Tofacitinib to its top destination countries
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | MICRO LABS LIMITED | $17.7K | 4 | 3 | $4.4K |
| 12 | ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED | $16.2K | 68 | 5 | $238 |
| 13 | 3S CORPORATION ★ | $16.1K | 51 | 1 | $316 |
3S Corporation ranks #13 among 119 Indian Tofacitinib exporters. Average shipment value of $316 compared to the market average of $9.9K. The closest competitors by value are MICRO LABS LIMITED and ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 203 | 24.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 179 | 22.0% |
| DELHI AIR CARGO ACC (INDEL4) | 105 | 12.9% |
| DELHI AIR | 82 | 10.1% |
| Bombay Air Cargo | 31 | 3.8% |
| Bombay Air | 30 | 3.7% |
| NHAVA SHEVA SEA (INNSA1) | 21 | 2.6% |
| Delhi Air | 19 | 2.3% |
3S Corporation also exports these advanced oncology products. Each links to the detailed product page.
3S Corporation exports 13 products worth $505.4K. Beyond Tofacitinib, top products include Cyclophosphamide, Warfarin, Procarbazine, Daunorubicin, Mefloquine. View the complete 3S Corporation profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Tofacitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for 3S Corporation's Tofacitinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
3S Corporation
Full Company Profile →
13 products · $505.4K total trade · 4 categories
| IRAQ |
| $81.5K |
| 25 |
| HARLEYS LIMITED | KENYA | $32.1K | 14 |
| ASTRA PHARMA (T) LTD | TANZANIA | $31.5K | 8 |
| ABACUS PHARMA (A) LTD | UGANDA | $30.5K | 7 |
| BALAXI HEALTHCARE GUATEMALA, S.A. | GUATEMALA | $13.4K | 4 |
India's Tofacitinib is purchased by 213 buyers worldwide. The top buyer is TARO PHARMACEUTICALS INC., (CANADA), followed by NILA JAMAL ENTERPRISE and TARO PHARMACEUTICALS INC..
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 67+ countries, 213+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for 3S Corporation.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tofacitinib. For current shipment-level data, contact TransData Nexus.